LMT

Analyst Note: Lockheed Martin Corporation (LMT)

Date: 2026-06-13 Current Price: $510.95

1. Structural Readiness

State: Context-Only Conservative Entry: — Breakout Level: — Extension: — ATR Current: 2.7% (Productive)

Analysis:

2. Thesis Layer

Primary Secular Thesis: Defense Modernization → Legacy Primes (Tier Direct). Conviction Weighting: High.

Lockheed Martin is a direct beneficiary of the "Defense Modernization" secular theme. As a legacy prime contractor, the company is positioned to capture the bulk of the U.S. government's accelerated procurement cycle. The evidence indicates a direct alignment with the administration's FY 2027 defense topline request, which seeks a historic $1.5 trillion defense budget. The company's product sets—specifically in munitions, integrated air and missile defense, and next-generation aircraft—are explicitly cited as well-aligned with these budget priorities. The thesis is reinforced by the "Golden Dome" missile defense initiative and the sustained demand for F-35 platforms, which serve as the backbone of the U.S. and allied air superiority strategies.

3. Business Overview

Business Model & Industry: Lockheed Martin operates as a global security and aerospace enterprise, specializing in the lifecycle of advanced technological systems. The company is structured into four key segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems, and Space. Its business model relies on long-term government contracts, primarily with the U.S. Department of War (DoD), supplemented by Foreign Military Sales (FMS).

Operational Evidence (as of 2026-06-13):

• Revenue Mix: In Q1 2026, 69% of sales ($18.0 billion) were derived from the U.S. Government, with 59% specifically from the DoD. International customers accounted for 31%.
• Production Ramp: Management announced plans to quadruple production capacity to meet accelerated demand. This includes a 3x expansion for PAC-3 interceptors and a 4x expansion for THAAD interceptors.
• Order Flow:
• F-16: Signed a $1.5 billion contract with the Peruvian Air Force for 12 Block 70 fighters, with an option for a second squadron.
• PAC-3: MFC was awarded $7 billion in orders, including a $4.8 billion fully funded undefinitized contract signed in Q1 2026.
• F-35: Delivered 32 aircraft in Q1 2026. Total deliveries since inception reached 1,325 units. The backlog stood at 336 aircraft as of March 29, 2026.
• Segment Performance:
• MFC: Sales increased 8% YoY ($276 million), driven by the PAC-3 ramp-up ($190 million) and tactical missile programs ($75 million).
• Space: Sales increased 7% YoY ($223 million), driven by strategic and missile defense programs (FBM and NGI).
• Financial Outlook: Management expects margins to improve in the second half of 2026 as production milestones are achieved. The 2026 outlook remains consistent with January guidance: mid-single-digit sales growth, profit of $8.4–$8.7 billion, and free cash flow of $6.5–$6.8 billion.

4. Archetype and Conviction

Archetype: Defensive Operator. Rationale: LMT fits the "Defensive Operator" archetype due to its high revenue visibility from long-term government contracts, disciplined capital allocation (dividend of $3.45/share declared in Q2 2026), and its role as a primary beneficiary of structural defense spending increases. The company is not a cyclical recovery play in the traditional sense but rather a structural growth play within a defensive sector.

Conviction Stack:

• Thesis Strength: High. The alignment with the $1.5 trillion FY 2027 budget request and the specific "Golden Dome" and munitions priorities provides a strong secular tailwind.
• Evidence Quality: Strong. The earnings transcript and SEC filings provide granular data on order awards, production ramp-ups, and segment performance.
• Structural Quality: High. The company is executing on a "quadruple production" mandate, addressing supply chain constraints that previously limited growth.
• Setup Readiness: Neutral/Unknown. The technical setup is currently undefined (context-only).
• Rerating Potential: Moderate. While the business fundamentals are robust, the market may be pricing in the "Golden Dome" controversy (see Risks) and the high cost of the defense budget.

Valuation Context: Forward consensus EPS for FY1 is $29.93 and FY2 is $32.03. The current price of $510.95 implies a forward P/E of approximately 17.1x for FY1 and 15.9x for FY2. This valuation reflects the company's status as a high-quality compounder with predictable cash flows, though it is not in a deep value recovery territory.

5. Invalidation, Strengthening, and Gaps

What Would Strengthen the Case:

• Margin Realization: Confirmation in the Q2 2026 earnings report that the anticipated margin improvements in the second half of 2026 are materializing as production milestones are hit.
• Order Acceleration: Additional large-scale FMS awards or domestic contracts beyond the current backlog, particularly in the Space or MFC segments.
• Production Milestones: Public confirmation that the "quadruple production" targets for PAC-3 and THAAD are being met ahead of schedule.

What Would Invalidate the Case:

• Budget Cuts: A significant reduction in the FY 2027 defense topline or a specific cancellation of the "Golden Dome" program that disproportionately impacts LMT's Space or MFC segments.
• Margin Erosion: A repeat of the unfavorable profit adjustments seen in Q1 2026 ($125M on F-16, $85M on C-130) that exceeds the $130M favorable adjustment on F-35, leading to a downward revision of the $8.4–$8.7 billion profit guidance.
• Supply Chain Breakdown: A failure to secure rare earth magnets or other critical components, preventing the execution of the production ramp-up.

Gaps in Evidence:

• Golden Dome Specifics: While the "Golden Dome" is a major budget item, the specific contract value awarded to Lockheed Martin versus competitors (like Rocket Lab or RTX) is not detailed in the provided evidence, creating a gap in quantifying LMT's direct exposure to this specific $1.2 trillion program.
• Q2 2026 Results: The current date is June 13, 2026. Q2 2026 results (ending June 29, 2026) have not yet been released. The "margin improvement" thesis relies on future execution that has not yet been reported.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: High Key evidence: 1) Direct alignment with $1.5T FY2027 defense budget and Golden Dome priority; 2) $7B PAC-3 award and $1.5B Peru F-16 contract confirming order flow; 3) Management guidance for margin improvement in H2 2026 as production ramps. Key risks: 1) Congressional pushback on the $1.2T Golden Dome cost estimate; 2) Continued supply chain vulnerabilities regarding rare earth magnets; 3) Execution risk on the aggressive production ramp-up targets. Sizing hint: Standard position size for a large-cap defensive operator with high conviction in the secular thesis. Expected path: Management executes production ramp, margins expand in H2 2026, and the company captures a significant share of the Golden Dome and munitions contracts. Expected horizon: 12 to 18 months for the thesis to fully play out through earnings realizations. Failure mode to watch: A significant downward revision to the 2026 profit guidance due to unresolved production delays or cost overruns.